Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 13.0B | 17.5B | 16.7B | 17.1B |
Cost of revenue | 10.5B | 13.9B | 13.1B | 13.5B |
Gross profit | 2.5B | 3.6B | 3.6B | 3.6B |
Operating expense | ||||
Research & development | 579.8M | 692.2M | 641.0M | 594.6M |
Selling general and admin | 1.5B | -509.6M | 2.9B | 479.5M |
Other operating expenses | 57.8M | 40.1M | 63.8M | 44.7M |
Operating income | 401.6M | 1.5B | 1.3B | 1.5B |
Non operating interest income | ||||
Income | 86.8M | 57.3M | 51.9M | 40.9M |
Expense | 16.7M | 25.9M | 16.5M | 21.5M |
Other income expense | — | — | — | — |
Pretax income | 596.7M | 1.9B | 1.3B | 1.5B |
Tax provision | 99.5M | 240.5M | 252.1M | 239.5M |
Net income | 497.2M | 1.7B | 1.1B | 1.2B |
Basic EPS | 0.4 | — | — | — |
Diluted EPS | 0.4 | — | — | — |
Basic average shares | 1.1B | — | — | — |
Diluted average shares | 1.1B | — | — | — |
EBITDA | 626.0M | 2.1B | 1.3B | 1.8B |
Net income from continuing op. | — | — | — | — |
Minority interests | -7.1M | -11.8M | -24.2M | -3.8M |
Preferred stock dividends | 0 | 0 | 0 | 0 |